DE69839844D1 - Verfahren zur auffindung von zielsuchenden verbindungen spezifisch für angiogenese vaskulatur - Google Patents

Verfahren zur auffindung von zielsuchenden verbindungen spezifisch für angiogenese vaskulatur

Info

Publication number
DE69839844D1
DE69839844D1 DE69839844T DE69839844T DE69839844D1 DE 69839844 D1 DE69839844 D1 DE 69839844D1 DE 69839844 T DE69839844 T DE 69839844T DE 69839844 T DE69839844 T DE 69839844T DE 69839844 D1 DE69839844 D1 DE 69839844D1
Authority
DE
Germany
Prior art keywords
target search
collecting target
angiogenic vasculature
compounds specific
search compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69839844T
Other languages
English (en)
Inventor
Erkki Ruoslahti
Renata Pasqualini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanford Burnham Prebys Medical Discovery Institute
Original Assignee
Sanford Burnham Prebys Medical Discovery Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/926,914 external-priority patent/US6576239B1/en
Priority claimed from US09/139,802 external-priority patent/US6180084B1/en
Application filed by Sanford Burnham Prebys Medical Discovery Institute filed Critical Sanford Burnham Prebys Medical Discovery Institute
Application granted granted Critical
Publication of DE69839844D1 publication Critical patent/DE69839844D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70546—Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69839844T 1997-09-10 1998-09-08 Verfahren zur auffindung von zielsuchenden verbindungen spezifisch für angiogenese vaskulatur Expired - Lifetime DE69839844D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/926,914 US6576239B1 (en) 1996-09-10 1997-09-10 Angiogenic homing molecules and conjugates derived therefrom
US09/139,802 US6180084B1 (en) 1998-08-25 1998-08-25 NGR receptor and methods of identifying tumor homing molecules that home to angiogenic vasculature using same
PCT/US1998/018895 WO1999013329A1 (en) 1997-09-10 1998-09-08 Methods of identifying molecules that home to angiogenic vasculature in tumors

Publications (1)

Publication Number Publication Date
DE69839844D1 true DE69839844D1 (de) 2008-09-18

Family

ID=26837556

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69839844T Expired - Lifetime DE69839844D1 (de) 1997-09-10 1998-09-08 Verfahren zur auffindung von zielsuchenden verbindungen spezifisch für angiogenese vaskulatur

Country Status (6)

Country Link
EP (1) EP1015884B1 (de)
JP (1) JP2001516055A (de)
AU (1) AU9477398A (de)
DE (1) DE69839844D1 (de)
HK (1) HK1029173A1 (de)
WO (1) WO1999013329A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524553B2 (en) 1998-03-31 2003-02-25 Bristol-Myers Squibb Pharma Company Quinolone vitronectin receptor antagonist pharmaceuticals
EA200001007A1 (ru) * 1998-03-31 2001-04-23 Дюпон Фармасьютикалз Компани Фармацевтические препараты для визуализации ангиогенных расстройств
US6537520B1 (en) 1998-03-31 2003-03-25 Bristol-Myers Squibb Pharma Company Pharmaceuticals for the imaging of angiogenic disorders
US6548663B1 (en) 1998-03-31 2003-04-15 Bristol-Myers Squibb Pharma Company Benzodiazepine vitronectin receptor antagonist pharmaceuticals
US6852318B1 (en) 1998-05-08 2005-02-08 The Regents Of The University Of California Methods for detecting and inhibiting angiogenesis
US6511649B1 (en) 1998-12-18 2003-01-28 Thomas D. Harris Vitronectin receptor antagonist pharmaceuticals
US6794518B1 (en) 1998-12-18 2004-09-21 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
CA2727746A1 (en) 1998-12-18 2000-06-22 Bristol-Myers Squibb Pharma Company Quinolone vitronectin receptor antagonist pharmaceuticals
AU2371400A (en) 1998-12-18 2000-07-03 Du Pont Pharmaceuticals Company Vitronectin receptor antagonist pharmaceuticals
US6569402B1 (en) 1998-12-18 2003-05-27 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
CN1419565A (zh) * 2000-01-21 2003-05-21 伯纳姆研究所 具有促细胞程序死亡活性的嵌合前列腺归巢肽
US7309694B2 (en) 2000-02-15 2007-12-18 Fondazione Centro San Raffaele Del Monte Tabor Modified cytokines for use in cancer therapy
IT1317835B1 (it) 2000-02-15 2003-07-15 San Raffaele Centro Fond Citochine modificate per uso nella terapia del cancro.
US7109303B2 (en) 2000-02-15 2006-09-19 Fondazione Centro San Raffaele Del Monte Tabor Modified cytokines for use in cancer therapy
AU2001268710A1 (en) * 2000-06-21 2002-01-02 Bristol-Myers Squibb Pharma Company Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy
WO2003006646A1 (en) * 2001-07-10 2003-01-23 Bayer Healthcare Ag Regulation of human aminopeptidase n
US7192921B2 (en) 2001-11-08 2007-03-20 The Burnham Institute Peptides that home to tumor lymphatic vasculature and methods of using same
EP1346729A1 (de) * 2002-03-19 2003-09-24 Cardiovascular Research Institute Maastricht Zielgerichtete Therapie der myokardialen Angiogenese durch CD13/APN
GB0209896D0 (en) 2002-04-30 2002-06-05 Molmed Spa Conjugate
US7488792B2 (en) 2002-08-28 2009-02-10 Burnham Institute For Medical Research Collagen-binding molecules that selectively home to tumor vasculature and methods of using same
AU2003298726A1 (en) * 2002-11-25 2004-08-10 Attenuon Llc Peptides which target tumor and endothelial cells, compositions and uses thereof
GB0312309D0 (en) 2003-05-29 2003-07-02 Gaslini Children S Hospital G Targeted liposome
EP1756165A2 (de) 2004-06-02 2007-02-28 Sidney Kimmel Cancer Center Gewebespezifische bildgebung und auf proteine, die auf der oberfläche von lungenendothelialzellen exprimiert werden, abzielende therapeutika
US20060024315A1 (en) 2004-06-02 2006-02-02 Sidney Kimmel Cancer Center Vascular targets for detecting, imaging and treating neoplasia or neovasculature
CN102558334B (zh) * 2004-09-07 2016-08-03 伯纳姆研究院 选择性锚定到心脏脉管系统上的肽和相关结合物和方法
GB0506183D0 (en) * 2005-03-24 2005-05-04 Univ Edinburgh Antigen detection
WO2017124147A1 (en) * 2016-01-19 2017-07-27 The University Of Western Australia Novel biomolecule conjugates and uses therefor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536814A (en) * 1993-09-27 1996-07-16 La Jolla Cancer Research Foundation Integrin-binding peptides
US5981478A (en) * 1993-11-24 1999-11-09 La Jolla Cancer Research Foundation Integrin-binding peptides
WO1997010507A1 (en) * 1995-09-11 1997-03-20 La Jolla Cancer Research Foundation Molecules that home to a selected organ or tissue in vivo and methods of identifying same
AU4412297A (en) * 1996-09-10 1998-04-02 Burnham Institute, The Tumor homing molecules, conjugates derived therefrom, and methods of using sa me

Also Published As

Publication number Publication date
EP1015884B1 (de) 2008-08-06
AU9477398A (en) 1999-03-29
HK1029173A1 (en) 2001-03-23
WO1999013329A1 (en) 1999-03-18
EP1015884A1 (de) 2000-07-05
JP2001516055A (ja) 2001-09-25

Similar Documents

Publication Publication Date Title
DE69839844D1 (de) Verfahren zur auffindung von zielsuchenden verbindungen spezifisch für angiogenese vaskulatur
DE69812693D1 (de) Verfahren zur oligomerisierung von isobuten
DE69939070D1 (de) Verfahren zur quantifizierung von menschlicher wachsamkeit
DE69714583D1 (de) Verfahren zur zerstäubung von flüssigkeiten
ATE318146T1 (de) Verfahren zur aufkonzentrierung von antikörperlösungen
DE69709061D1 (de) Verfahren zur umsetzung von ethylbenzol
DE69817839D1 (de) Verfahren zur erhöhung der photosynthese
DE69522486D1 (de) Verfahren zur Verfolgung beweglicher Körper
DE50010474D1 (de) Verfahren zur verkapselung von bauelementen
DE59404339D1 (de) Verfahren zur scheinzielerzeugung
DE69727395D1 (de) Verfahren zur olefinisomerisierung
DE69719722D1 (de) Verfahren zur identifizierung von beweglichen objekten
DE69715234D1 (de) Verfahren zur reinigung von 1,1-difluorethan
DE59305971D1 (de) Verfahren zur entölung von rohlecithin
DE69725406D1 (de) Verfahren zur Kühlung von Leitschaufeln
DE69711068D1 (de) Verfahren zur kristallisation von losartan
DE59807818D1 (de) Verfahren zur zielklassifizierung
DE59806044D1 (de) Verfahren zur ermittlung von segmentzeiten
DE69935929D1 (de) Verfahren zur reinigung von blutbestandteilen
DE69904971D1 (de) Verfahren zur Abtrennung von Serum aus Vollblut
DE69710078D1 (de) Verfahren zur reinigung von 1,1,1,3,3-pentafluorpropan
DE59706891D1 (de) Verfahren zur abtrennung von acrylsäure
DE59706134D1 (de) Verfahren zur ermittlung der funktionstauglichkeit von schmierölen
DE59807142D1 (de) Verfahren zur reinigung von anlagenteilen
DE59703815D1 (de) Verfahren zur hydroformylierung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition